Korro Bio, Inc.
KRRONasdaqCIK 1703647HealthcareFiscal year ends Dec 31
Reports and events: 140 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2207:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-428306 |
| 2026-10-0516:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-414118 |
| 2026-08-1916:05 ET | 8-K | 8.01 Other events | 0001193125-26-356877 |
| 2026-08-0607:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336707 |
| 2026-08-0607:04 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-336685 |
| 2026-08-0417:13 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001708269-26-000005 |
| 2026-06-1116:42 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-267741 |
| 2026-05-1907:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229610 |
| 2026-05-0707:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-210303 |
| 2026-05-0707:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210291 |
| 2026-04-1607:00 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001193125-26-157895 |
| 2026-03-1219:32 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-26-000267 |
| 2026-03-1216:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-104156 |
| 2026-03-1216:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-104135 |
| 2026-03-0907:35 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097575 |
| 2026-01-2709:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-023436 |
| 2026-01-1516:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-014087 |
| 2025-12-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-324795 |
| 2025-11-1216:09 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277572 |
| 2025-11-1216:08 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-277556 |
| 2025-10-0807:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-234001 |
| 2025-08-1207:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106912 |
| 2025-08-1207:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106910 |
| 2025-06-1817:00 ET | 8-K/A | 5.07 Shareholder vote results | 0000950170-25-087949 |
| 2025-06-1116:23 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-084846 |
| 2025-05-0716:40 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065800 |
| 2025-05-0716:35 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-25-065786 |
| 2025-04-2906:05 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0000950170-25-059533 |
| 2025-03-2709:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-064792 |
| 2025-03-1807:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-040759 |
| 2025-03-1807:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-040755 |
| 2025-02-1116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-024305 |
| 2025-01-1308:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-005020 |
| 2024-11-2107:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-129488 |
| 2024-11-1216:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125362 |
| 2024-11-1216:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125347 |
| 2024-11-0407:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-120282 |
| 2024-09-1608:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-106611 |
| 2024-08-2816:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-101395 |
| 2024-08-1316:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096189 |
| 2024-08-1316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096172 |
| 2024-06-2116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-165684 |
| 2024-06-1216:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-159933 |
| 2024-05-1416:34 ET | S-1 | Registration statement | 0001193125-24-138296 |
| 2024-05-1416:03 ET | 8-K | 8.01 Other events | 0000950170-24-059498 |
| 2024-05-1416:02 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059493 |
| 2024-05-1416:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-059491 |
| 2024-04-2907:42 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001193125-24-119912 |
| 2024-04-2419:33 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000402 |
| 2024-04-2217:09 ET | 8-K | 8.01 Other events | 0001193125-24-105037 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:32 ET. Listed shows no prices and gives no investment advice.